Anpario plc Revenue and Competitors

Worksop, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Anpario plc's estimated annual revenue is currently $14.7M per year.(i)
  • Anpario plc's estimated revenue per employee is $155,000

Employee Data

  • Anpario plc has 95 Employees.(i)
  • Anpario plc grew their employee count by 0% last year.

Anpario plc's People

NameTitleEmail/Phone
1
VP Sales North AmericaReveal Email/Phone
2
VP Finance and Operations the Americas; U.S. National Ruminant Sales ManagerReveal Email/Phone
3
Group Technical DirectorReveal Email/Phone
4
Group Commercial DirectorReveal Email/Phone
5
Commercial Director AustralasiaReveal Email/Phone
6
Corporate Development DirectorReveal Email/Phone
7
Commercial Director EU and BeyondReveal Email/Phone
8
Commercial DirectorReveal Email/Phone
9
Product Technical Manager - RuminantReveal Email/Phone
10
Technical Product ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$113148.5M329879N/AN/AN/A
#2
$50790M1046290%$2.5M$258.8B
Add Company

What Is Anpario plc?

Anpario offers natural solutions that work in harmony with the natural aspects of the animal's biology to promote healthy growth. Anpario supplies its customers with quality assured products manufactured in the United Kingdom and has an established global sales and distribution network in over 70 countries. Anpario is listed on the AIM stock exchange and has been built up of a combination of three UK founded companies, Meriden Animal Health, Kiotechagil and Optivite. Since their acquisitions, Anpario has made gradual internal changes to combine and standardise systems and processes, to become one company. Anpario has brought together cutting-edge product technologies and has a broad range of speciality feed additive products, including pioneering products such as Orego-Stim and Salkil. The portfolio of innovative products work in harmony with the natural aspects of the animal's biology to promote healthy growth.The portfolio is divided into four product categories, Eubiotics, Feed Security, Feed Quality and Nutritional.

keywords:Biotechnology,Healthcare

N/A

Total Funding

95

Number of Employees

$14.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Anpario plc News

2022-04-17 - Anpario PLC 32.0% potential upside indicated by Canaccord ...

Anpario PLC with ticker (LON:ANP) now has a potential upside of 32.0% according to Canaccord Genuity. Canaccord Genuity set a target price...

2022-04-13 - Anpario (LON:ANP) Receives Buy Rating from Canaccord ...

Anpario plc logo Canaccord Genuity Group reaffirmed their buy rating on shares of Anpario (LON:ANP – Get Rating) in a research note released...

2022-04-06 - Anpario's (LON:ANP) Upcoming Dividend Will Be Larger Than Last Year's

Anpario plc's (LON:ANP) dividend will be increasing to UK£0.07 on 29th of July. Even though the dividend went up, the yield is still quite...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.5M1055%N/A
#2
$72.9M2029%N/A
#3
$15M2607%N/A
#4
$187.1M7778%N/A